​

Funding Round

Series C - Adarza BioSystems

Series C - Adarza BioSystems

Investment Firm

Overview

Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.

Announced Date

Jan 19, 2017

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

RiverVest

RiverVest

RiverVest is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

6

Investor Name
Participant InvestorLewis & Clark Ventures
Participant InvestorGenoa Ventures
Participant InvestorRiverVest
Participant InvestorSerra Ventures
Participant InvestorCSC Upshot

Round Details and Background

Adarza BioSystems raised $17000000 on 2017-01-19 in Series C

Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 09, 2014
Series A - Adarza BioSystems
2-2.0M
Oct 02, 2014
Series A - Adarza BioSystems
3-4.0M
Jul 18, 2013
Seed Round - Adarza BioSystems
1-250.0K
Apr 17, 2013
Seed Round - Adarza BioSystems
2-undefined

Recent Activity

There is no recent news or activity for this profile.